Episode Player

Hair Loss in Men: Treating Male Pattern Baldness

Clinical Capsules - Actionable Medication Pearls in Minutes

Clinical Capsules - Actionable Medication Pearls in Minutes
Hair Loss in Men: Treating Male Pattern Baldness
Apr 28, 2026 Season 2 Episode 8
TRC Healthcare

Male pattern baldness is more than a cosmetic concern – and patients often turn to the pharmacy first for answers.

In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Don Weinberger, PharmD, PMSP, discusses treating male pattern baldness. He reviews the underlying mechanism of hair loss and compares evidence-based treatment options, including oral finasteride, topical minoxidil, and more. Don also provides practical counseling points, including adverse effects, expected timelines for hair regrowth, and why the effects are typically not permanent once treatment is stopped. 

This is an excerpt from our January 2026 Pharmacy Essential Updates continuing education webinar series.

🏷️ Use code cc1026 at checkout for 10% off a new or upgraded subscription. 

******

CE Information:

TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose.

Claim Credit

******

Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights

Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. 

🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter.

🗪 Send us Fan Mail

Email us: ContactUs@trchealthcare.com

The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. 

Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.

Learn more about our product offerings at trchealthcare.com.